Competitive Salary: F. Hoffmann-La Roche AG: The PositionGenentech is inviting applications for a Computational Biologist to join the Department of Human Genetics as a Senior Scientist. Genentech San Francisco, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionWe are seeking a talented and highly motivated Sub-Chapter lead for the Next Generation Sequencing (NGS) algorithms development team at th Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Roche Sequencing Solutions (RSS), a business within Roche Diagnostics, is focused on developing a disruptive Next-Generation Sequencing (NGS) platform United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThis position may be based out of Santa Clara, CA, USA, with remote work locations possible in The United States.Impact HealthcareRoche Se Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThe candidate will bring technical expertise into our molecular oncology CLIA laboratory. The laboratory performs high complexity NGS test San Jose, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionResponsibilitiesProvide technical and strategic leadership as a member of the lifecycle project teams to support decision making in assay Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Impact HealthcareRoche Sequencing is developing ground-breaking next-generation sequencing products that allow scientists/clinicians powerful new aven Santa Clara, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionPlease note this position has the potential to support a remote work arrangement and may be based anywhere in the United StatesAt Roche, 9 United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionThe OMNI Bioinformatics and Immunology departments at Genentech are seeking a highly motivated computational scientist to engage in therap San Francisco, California (US)

Competitive Salary: F. Hoffmann-La Roche AG: Impact HealthcareRoche Sequencing is not only changing science, but we are changing lives. Our software teams are laying the groundwork for the future Ottawa (Region), Ontario (CA)

Competitive Salary: F. Hoffmann-La Roche AG: As the Head of Assay Bioinformatics, Molecular Lab Applications you will play a key role in setting technical strategy and driving execution for devel United States (US)

Competitive Salary: F. Hoffmann-La Roche AG: The PositionGenentech seeks a talented and highly motivated Bioinformatics Software Engineer with expert knowledge of modern genomic data processing w San Francisco, California (US)

Funding Opportunity RFA-HD-23-013 from the NIH Guide for Grants and Contracts. This FOA invites applications to participate in a research program cooperative agreement to support the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN). The Network will expand successes achieved by PATC3H to new geographic settings with limited implementation science (IS) research capacity and/or risk populations who are poorly represented in international adolescent HIV research (e.g. sexual and gender minorities; commercial sex workers; drug users) and stimulate much needed IS research in a neglected area of public health significance: prevention of new HIV infections among adolescents at risk and the identification of, and linkage and retention to care of and long-term viral suppression among youth living with HIV in low-to-middle income countries (LMICs). These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV incidence among youth ages 10 to 24 years of 0.01% or more.

Funding Opportunity RFA-HD-23-014 from the NIH Guide for Grants and Contracts. This FOA invites applications to participate in a research program cooperative agreement to support the Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN). The Network will expand successes achieved by PATC3H to new geographic settings with limited implementation science (IS) research capacity and/or risk populations who are poorly represented in international adolescent HIV research (e.g. sexual and gender minorities; commercial sex workers; drug users) and stimulate much needed IS research in a neglected area of public health significance: prevention of new HIV infections among adolescents at risk and the identification of, and linkage and retention to care of and long-term viral suppression among youth living with HIV in low-to-middle income countries (LMICs). These settings must have an HIV epidemic density defined by UNAIDS estimates as either a country 1) in which at least 200,000 people are living with HIV and the number has not decreased by more than 5% over the last 2 consecutive years of available data or 2) has an HIV incidence among youth ages 10 to 24 years of 0.01% or more.

Funding Opportunity RFA-MH-22-240 from the NIH Guide for Grants and Contracts. The goal of this effort is to support the development and validation of next generation platforms and analytic approaches to precisely quantify behaviors in humans and link them with simultaneously recorded brain activity. Tools used for analyzing behavior should be multi-modal and should be able to be linked to brain activity and thus have the accuracy, specificity, temporal resolution, and flexibility commensurate with tools used to measure and modulate the brain circuits that give rise to those behaviors. This phased award will support novel tool development (i.e., hardware/software) in the R61 phase and synchronization of novel tools for measuring behavior and human brain activity in the R33 phase.

Funding Opportunity RFA-NS-23-004 from the NIH Guide for Grants and Contracts. The purpose of this Limited Competition Funding Opportunity Announcement is to allow Undiagnosed Diseases Network (UDN) Clinical Sites that received an NIH award under RFA-RM-17-019 an opportunity to compete for one additional year of NIH funding to: continue their participation in the UDN; establish collaborations and efficient processes with the next phase Data Management and Coordinating Center (DMCC; see: RFA-NS-22-051); enroll and evaluate new participants; and further develop their sustainability plans.

Notice NOT-HL-22-041 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-186 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-22-019 from the NIH Guide for Grants and Contracts. This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders in T1D research, particularly those from diverse communities that experience diabetes-related health disparities, as well as the healthcare and social systems that impact community members and patients health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.

Competitive Salary: F. Hoffmann-La Roche AG: Roche Sequencing is not only changing science, but we are changing lives. Our software teams are laying the groundwork for the future by developing po Santa Clara, California (US)